Fat embolization prophylaxis. Use of hypertonic glucose.
D002784:Cholesterol / Q000097:blood; D003348:Cortisone / Q000378:metabolism; D004620:Embolism, Fat / Q000517:prevention & control*; D004804:Eosinophils; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005264:Femoral Fractures / Q000150:complications; D050723:Fractures, Bone / Q000150:complications; D005947:Glucose / Q000008:administration & dosage*; D006801:Humans; D006982:Hypertonic Solutions; D007275:Injections, Intravenous; D007958:Leukocyte Count; D008055:Lipids / Q000097:blood; D008074:Lipoproteins / Q000097:blood; D008111:Liver Function Tests; D009638:Norepinephrine / Q000378:metabolism; D010388:Pelvis / Q000293:injuries; D013978:Tibial Fractures / Q000150:complications; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014947:Wounds and Injuries / Q000150:complications*
D005230:Fatty Acids, Nonesterified; D006982:Hypertonic Solutions; D008055:Lipids; D008074:Lipoproteins; D014280:Triglycerides; D002784:Cholesterol; D005947:Glucose; D003348:Cortisone; D009638:Norepinephrine